Comparison of Biolimus-eluting Biodegradable Polymer, Everolimus-eluting and Sirolimus-eluting Coronary Stents.
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 10 Apr 2014
At a glance
- Drugs Everolimus (Primary) ; Umirolimus (Primary)
- Indications Coronary artery restenosis
- Focus Therapeutic Use
- Acronyms BESS
- 11 Feb 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 20 Jul 2012 According to ClinicalTrials.gov record, sirolimus-eluting stent treatment arm has been deleted. Now the trial consists of only 2 arms- biolimus-eluting and everolimus-eluting stent.
- 20 Jul 2012 Planned number of patients changed from 3000 to 1462 as reported by ClinicalTrials.gov.